scholarly journals Current Trends and Impact of Smoking Cessation Interventions for Adult Smokers in Low and Middle Income Countries: A Systematic Literature Review

2014 ◽  
Vol 11 (1) ◽  
pp. 37-49
Author(s):  
Olusegun Owotomo

Objective: This study aims to systematically review the existing literature on the current developments and impact of smoking cessation interventions targeted toward adult smokers in low and middle income countries (LMICs).Methods: Major databases were searched with the following selection criteria: (1) studies based on empirical findings that demonstrate the impact of smoking cessation interventions in LMICs; (2) studies conducted in or focused on LMICs; (3) studies targeted at the adult smoking population; (4) studies focused on smoking cessation component of tobacco control; (5) studies that reported on the capacity for smoking cessation intervention and current developments in LMICs; (6) published in peer review journals between 2003 and April, 2013; (7) studies written or transcribed in English.Results: A total of 23 articles (23 studies) were included in the review. Six studies assessed the effectiveness and cost-effectiveness of smoking cessation intervention types in some LMICs. Four studies explored the reach, adoption and institutionalisation of cessation interventions. Six studies assessed physicians’ capacity to provide cessation interventions, and seven studies provided insights on current developments.Conclusion: Smoking cessation interventions are not readily available and affordable in LMICs. Extensive research is needed to determine the most cost-effective and culturally appropriate smoking cessation interventions for adult smokers in LMICs.

Author(s):  
Chris Bullen ◽  
Jessica McCormack ◽  
Amanda Calder ◽  
Varsha Parag ◽  
Kannan Subramaniam ◽  
...  

Abstract Background: The global COVID-19 pandemic has disrupted healthcare worldwide. In low- and middle-income countries (LMICs), where people may have limited access to affordable quality care, the COVID-19 pandemic has the potential to have a particularly adverse impact on the health and healthcare of individuals with noncommunicable diseases (NCDs). A World Health Organization survey found that disruption of delivery of healthcare for NCDs was more significant in LMICs than in high-income countries. However, the study did not elicit insights into the day-to-day impacts of COVID-19 on healthcare by front-line healthcare workers (FLHCWs). Aim: To gain insights directly from FLHCWs working in countries with a high NCD burden, and thereby identify opportunities to improve the provision of healthcare during the current pandemic and in future healthcare emergencies. Methods: We recruited selected frontline healthcare workers (general practitioners, pharmacists, and other medical specialists) from nine countries to complete an online survey (n = 1347). Survey questions focused on the impact of COVID-19 pandemic on clinical practice and NCDs; barriers to clinical care during the pandemic; and innovative responses to the many challenges presented by the pandemic. Findings: The majority of FLHCWs responding to our survey reported that their care of patients had been impacted both adversely and positively by the public health measures imposed. Most FLHCs (95%) reported a deterioration in the mental health of their patients. Conclusions: Continuity of care for NCDs as part of pandemic preparedness is needed so that chronic conditions are not exacerbated by public health measures and the direct impacts of the pandemic.


2018 ◽  
Vol 66 (10) ◽  
pp. 1487-1491 ◽  
Author(s):  
Jean B Nachega ◽  
Nadia A Sam-Agudu ◽  
Lynne M Mofenson ◽  
Mauro Schechter ◽  
John W Mellors

Abstract Although significant progress has been made, the latest data from low- and middle-income countries show substantial gaps in reaching the third “90%” (viral suppression) of the UNAIDS 90-90-90 goals, especially among vulnerable and key populations. This article discusses critical gaps and promising, evidence-based solutions. There is no simple and/or single approach to achieve the last 90%. This will require multifaceted, scalable strategies that engage people living with human immunodeficiency virus, motivate long-term treatment adherence, and are community-entrenched and ‑supported, cost-effective, and tailored to a wide range of global communities.


Sign in / Sign up

Export Citation Format

Share Document